MAP2K3 antibody (C-Term)
Quick Overview for MAP2K3 antibody (C-Term) (ABIN6944069)
Target
See all MAP2K3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Purpose
- MEK3 (4C1) Monoclonal Antibody
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- Human MEK3 aa 150 to the C-terminus
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000), FCM(1:20-100), IHC-P(1:200-400), IF(ICC)(1:50-200), IHC()
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
-
Alternative Name
- MEK3
-
Background
-
Synonyms: Dual specificity mitogen-activated protein kinase kinase 3, MAPK/ERK kinase 3, Stress-activated protein kinase kinase 2, MAP kinase kinase 3, MAPKK 3, MEK 3, SAPK kinase 2, SAPKK-2, SAPKK2, MAP2K3
Background: Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14.
-
Gene ID
- 5606
-
UniProt
- P46734
-
Pathways
- MAPK Signaling, TLR Signaling, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-